SIMPARICA, created in 2015 (United States), belongs to our Top Web Popularity Drug Manufacturers, from 218 sister brands and 4959 competing brands. The SIMPARICA brand is owned by Zoetis, a company listed in New York. SIMPARICA belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
Zoetis
(SIMPARICA)
over 5 years*
USD 282.89